tates the sequential phosphorylation events required for proteins with molecular masses of 65, 55, and 36 kDa revealed peptides from three subunits of the serine/ ERK activation.
Recent studies have revealed that C-TAK1 is the kithreonine phosphatase PP2A, namely the PR65/A␣, PR55/B␣, and catalytic/C␤ subunits, respectively (Fignase that phosphorylates KSR1 on S392 in quiescent cells [4] . However, the molecular mechanisms responsiure 1B). It should be noted that no PP2A peptides were detected in control samples prepared from untransble for the inductive dephosphorylation of the KSR1 S392 site have not been elucidated. In this study, we fected cells and that PP2A was the only phosphatase identified in the KSR1 complexes. PP2A is a heterotrishow that the protein phosphatase PP2A is a component of the KSR1 scaffolding complex and find that PP2A meric protein composed of a dimeric core enzyme (the structural A and the catalytic C subunits) and a regulaactivity is required for the stimulus-induced dephosphorylation of S392. Moreover, our results indicate that tory subunit (B-type subunits) (reviewed in [23] ). Thus, the entire PP2A holoenzyme is detected in KSR1 comdephosphorylation of both KSR1 and the Raf-1 kinase by PP2A is needed for KSR1-mediated MAPK activation. plexes isolated from cycling cells. These findings demonstrate the importance of PP2A as a regulator of Ras signaling.
Growth Factor Treatment Induces Interactions between PP2A and KSR1
To confirm the KSR1/PP2A interaction and to localize Results the region of KSR1 required for PP2A binding, various KSR-1 deletion mutants were tested for their ability to PP2A Is a Component of the KSR1 Complex KSR1 has been shown to be part of a high molecular associate with the A, B, and C subunits of PP2A. For this analysis, the KSR1 proteins were expressed in cyweight complex (300-500 kDa) in mammalian cells [21, 22] . To further characterize this complex and to isolate cling Cos cells and lysates were prepared under more stringent lysis conditions using buffers containing 1% potential regulators of KSR1 function, we used mass spectrometry to identify the proteins associating with NP-40. Subsequent examination of the KSR1 complexes revealed that all three PP2A subunits were present in the KSR1 scaffold. Pyo-tagged KSR1 proteins were expressed in cycling Cos cells, and extracts were prepared immunoprecipitates of the N-terminal NЈ539, NЈ424, and NЈ320 KSR1 proteins, but not in samples containing the using a lysis buffer optimized to maintain protein interactions (0.2% Triton X-100 lysis buffer). The KSR1 com-N-terminal NЈ249 mutant or the C-terminal CЈ542 protein (Figure 2A ). These findings confirm the mass spectromeplexes were then isolated using covalently coupled antiPyo affinity beads. The complexes were separated by try analysis and localize the binding site for PP2A to residues 249-320 of KSR1. one-dimensional SDS-PAGE and visualized by Coomassie blue staining ( Figure 1A ). Proteins were extracted Because the above experiments were conducted with cycling cells, they do not distinguish whether the interfrom the gel matrix by trypsin digestion and analyzed by ion trap mass spectrometry. Using this approach, we action of the PP2A subunits with KSR1 is constitutive or inducible. To address this issue, we examined the identified peptides from several known KSR1-interacting proteins, including Hsp90, Hsp70, p50/Cdc37, effects of serum starvation and growth factor treatment on the KSR1/PP2A interaction. NIH3T3 cells were in-MEK1, MEK2, ERK1, ERK2, C-TAK1, and 14-3-3 [6, 21]; however, no peptides from the Raf family of kinases fected with a recombinant adenovirus expressing wildtype (wt) KSR1. KSR1 complexes were then isolated were obtained. In addition, analysis of KSR1-associated not change upon growth factor addition. In contrast, binding of the regulatory B subunit was dramatically increased by PDGF treatment. These data indicate that the PP2A core enzyme is a constitutive component of the KSR1 complex, whereas the regulatory B subunit interaction is induced by Ras pathway activation.
To investigate the biological relevance of the KSR1/ PP2A interaction, the association of endogenous KSR1 and PP2A proteins was examined. KSR1 immunoprecipitates were prepared from mouse brain, a tissue that expresses high levels of both KSR1 and PP2A and where endogenous complex formation between KSR1, MEK, MAPK, C-TAK1, and 14-3-3 has been demonstrated [4]. The A and C core subunits were readily detected in the KSR1 immunoprecipitates from brain lysates, but much lower levels of the B subunit were observed ( Figure 2C and data not shown). The weak detection of the B subunit is consistent with the idea that the B subunit interaction is inducible and therefore would not be expected to occur in all cells; however, it could also indicate that other B-type subunits associate with KSR1 in brain tissue. Nonetheless, these findings demonstrate the endogenous interaction of KSR1 with the PP2A catalytic core subunits in a biologically relevant setting. . These events also serve to colocalize site were localized constitutively at the plasma membrane even in serum-starved cells. Strikingly, treatment MEK and ERK with activated Raf-1 at the plasma membrane, thereby facilitating MEK and ERK activation. To of cells with OA prior to PDGF stimulation prevented the localization of wt KSR1 to the plasma membrane ruffles gain further insight into how PP2A activity affects MAPK signaling via KSR1, we investigated whether activation but had no effect on the translocation of S392A KSR1.
In Vivo Dephosphorylation of S392 and Membrane
of KSR1-associated MEK and ERK were dependent on PP2A activity. Serum-starved wt KSR1-expressing NIH3T3 PP2A Activity Is Required for Activation of KSR1-Associated MEK and MAPK cells were left untreated or were treated with OA prior to growth factor stimulation. KSR1 complexes were isoThe release of 14-3-3 from the KSR1 S392 site and the subsequent translocation of the KSR1 complex to the lated and examined using antibodies that specifically recognize the activated phosphorylated forms of MEK and ERK (P-MEK or P-ERK), as well as those recognizing total MEK and ERK levels. As shown in Figure 3C , the overall level of KSR1-associated MEK did not vary with PDGF treatment; however, activated MEK was only detected in KSR1 immunoprecipitates after PDGF addition. When PP2A activity was inhibited by OA prior to PDGF treatment, the total level of KSR1-associated MEK remained unaltered, whereas detection of activated MEK in KSR1 complexes was nearly abolished. As previously observed, growth factor stimulation was required for the binding of ERK to KSR1 and for the detection of activated ERK in the KSR1 samples ( Figure 3C ). Treatment with OA disrupted the interaction between KSR1 and ERK, such that little or no activated ERK was detected in the complexes. Thus, PP2A inhibition disrupts the activation of KSR1-associated MEK and ERK, consistent with the findings that this inhibition also blocks S392 dephosphorylation and KSR1 membrane localization.
Dephosphorylation of Both KSR1 and Raf-1 by PP2A Is Required for KSR1-Mediated MAPK Pathway Activation
The dimeric core subunits of PP2A have also been reported to interact with Raf-1, and studies indicate that PP2A contributes to Raf-1 activation by dephosphorylating S259, a negative regulatory site on Raf-1 that confers 14-3-3 binding [26] [27] [28] . In addition, these reports showed that although PP2A inhibition blocked activation of wt Raf-1, it had little effect on Raf-1 mutated at the S259 site. Therefore, it is possible that the lack of activated MEK in KSR1 complexes isolated from OAtreated cells could be due to Raf-1 inhibition rather than a defect in KSR1 membrane localization. First, to confirm the importance of PP2A to Raf-1 signaling in our system, Pyo-tagged Raf-1 complexes were isolated from cycling Cos cells and examined for the presence of PP2A by mass spectrometry. As was observed for KSR1 complexes, peptides from the PR65/A␣, PR55/B␣, and catalytic/C␤ subunits of PP2A were detected in the Raf-1 was detected in wt KSR1 complexes isolated from cells subunits constitutively interact forming a core complex, to which one of several B subunits can bind. Binding of coexpressing either wt or S259A Raf-1, indicating that when PP2A activity is inhibited, Raf-1 activation alone B-type subunits increases enzymatic activity and can modulate the subcellular localization and substrate is insufficient to promote phosphorylation of wt KSR1-associated MEK and ERK. In contrast, complexes of specificity of the holoenzyme. In addition, PP2A activity can be further regulated by posttranslational modifica-S392A KSR1, the mutant exhibiting constitutive membrane localization, did contain activated MEK and ERK, tions to the catalytic C subunit and by the binding of inhibitory proteins and other viral or cellular cofactors. but only when isolated from cells coexpressing S259A Raf-1. These results show that both the membrane localUsing mass spectrometry, here we report that the PR65/A, PR55/B, and catalytic/C subunits of PP2A are ization of KSR1 and the activation of Raf-1 are required for KSR1 to promote Ras-dependent activation of MEK present in KSR1 complexes isolated from cycling cells.
Coimmunoprecipitation assays confirmed this interacand ERK.
tion and demonstrated the association of endogenous PP2A and KSR1 in murine brain. Although it is unclear Discussion whether this interaction is direct, residues 249-320 of the KSR1 N-terminal domain were found to be required A key feature of mammalian MAPK scaffolding proteins is their ability to regulate the spatiotemporal activation for the association of all three PP2A subunits. Further characterization of these interactions revealed that of MAPK components. For KSR1, its scaffolding function requires that it be translocated from the cytosol to the while the binding of the dimeric core complex was constitutive, the interaction between KSR1 and the PP2A plasma membrane, an event regulated by dephosphorylation of a critical 14-3-3 binding site-S392. In this reregulatory B subunit increased dramatically following Ras pathway activation. The underlying mechanism(s) port, we identify PP2A as a component of the KSR1 complex and find that PP2A mediates the dephosphoryfor why binding of the B subunit is induced by growth factor treatment are currently unknown; however, incorlation of S392. Our findings provide new insight into the regulation of KSR1 function and further elucidate the poration of the B subunit into the complex would be expected to increase the catalytic activity of PP2A tomolecular mechanisms whereby PP2A contributes to Ras/MAPK signal transduction.
ward KSR1. Indeed, we do find that KSR1 is a substrate of PP2A PP2A is an essential serine/threonine phosphatase found in all eukaryotic organisms. It is a heterotrimeric and that PP2A activity is required for the dephosphorylation event mediating the membrane recruitment of enzyme that consists of a structural A, catalytic C, and regulatory B subunits (reviewed in [23] ). The A and C KSR1. Despite its constitutive association with the PP2A lated by PP2A are consistent with these genetic inferpromotes its membrane recruitment and activation, due ences. Moreover, our findings that PP2A activity is apparently to an increased binding affinity for activated required for KSR1 to promote ERK pathway activation Ras [27, 28] . The dimeric core subunits of PP2A have defines a biochemical mechanism for how PP2A can been reported to interact with Raf-1 [26] , and PP2A has function as a positive effector of Ras signaling. been implicated in the dephosphorylation of Raf-1 at S259 [26, 27] . In our studies, we find that the PP2A core 
